Molecular Imaging Diagnostics
ABSCINT is a clinical stage
molecular imaging company that develops in-vivo diagnostics based on single
ABSCINT focuses on the development of radiolabelled single domain antibodies for whole body molecular imaging applications. Molecular imaging is used for the diagnosis of disease, for molecular characterisation of a disease, for monitoring treatment response and for detection of disease recurrence. It is based on specific molecular markers that can be visualised over the entire body by a short scan.
The company has two clinical stage products: one in oncology and one in cardiovascular disease.